These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28828599)

  • 21. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.
    Nguyen TT; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2989-2998. PubMed ID: 28766214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
    Wehner P; Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
    Raldow AC; Sher D; Chen AB; Recht A; Punglia RS
    J Clin Oncol; 2016 Nov; 34(33):3963-3968. PubMed ID: 27621393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
    Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
    J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study.
    Bodilsen A; Bjerre K; Offersen BV; Vahl P; Ejlertsen B; Overgaard J; Christiansen P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S476-85. PubMed ID: 26178760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
    Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
    Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
    Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
    Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
    Cronin PA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2016 Sep; 23(9):2816-24. PubMed ID: 27198513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial.
    Strell C; Folkvaljon D; Holmberg E; Schiza A; Thurfjell V; Karlsson P; Bergh J; Bremer T; Akslen LA; Wärnberg F; Östman A
    Clin Cancer Res; 2021 Jun; 27(12):3469-3477. PubMed ID: 33952629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
    Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
    Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of multiple re-excisions after lumpectomy for breast cancer.
    Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
    Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.